Early Clinical Outcomes of Cultured Human Corneal Endothelial Cell Injection (Vyznova) for Bullous Keratopathy: Initial Clinical Experience
Vyznova therapy seems to be effective in restoring corneal clarity in patients with BK. This real-world experience underscores the feasibility of implementing cHCEC injections in institutions beyond the developer sites. Careful intraoperative management is necessary to avoid complications, such as detachment of Descemet membrane.
Authors
- Takefumi Yamaguchi (ORCID: https://orcid.org/0000-0002-2546-2813)
- Hideaki Yokogawa (ORCID: https://orcid.org/0000-0001-6056-5271)
- Yukari Yagi-Yaguchi (ORCID: https://orcid.org/0000-0002-7980-7741)
- Natsuko Mori
- Akira Kobayashi (ORCID: https://orcid.org/0000-0001-8190-6776)
- Seiichiro Sugita
- Tomomi Higashide (ORCID: https://orcid.org/0000-0001-9566-4587)
Institutions
- Kanazawa University (JP)
- Tokyo Dental College Ichikawa General Hospital (JP)
- Miyake Eye Hospital (JP)
Publication Details
- Journal
- Cornea
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1097/ico.0000000000003984
- Citations
- 1
- Primary Topic
- Corneal surgery and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.36